江苏必易生物科技

Jiangsu Biyi Biotechnology Co., Ltd., founded in 2019, is a comprehensive pharmaceutical technology service enterprise based in Haimen, Nantong, Jiangsu Province, China. The company operates as one of the industry's first Marketing Authorization Holder (MAH) platform enterprises, focusing on drug research and development, MAH holding, and pharmaceutical sales. Its product portfolio includes generic small molecule drugs such as aspirin enteric-coated tablets, rabeprazole sodium enteric-coated tablets, ibuprofen sustained-release capsules, and pilocarpine nitrate tablets. Jiangsu Biyi Biotechnology is expanding its capabilities from a medical technology R&D institution to a fully integrated MAH platform and downstream formulation production.